PremiumCompany AnnouncementsFusion Antibodies Achieves 71% Revenue Growth Amid Strategic Diversification Fusion Antibodies Announces Total Voting Rights and Share Capital Details Fusion Antibodies Secures Grant for Cancer Treatment Development PremiumCompany AnnouncementsFusion Antibodies Secures £1.17 Million in Conditional Share Placing Fusion Antibodies Secures New Cell Line Development Contract Fusion Antibodies Advances OptiMAL® Project with NCI Collaboration PremiumCompany AnnouncementsFusion Antibodies Plc Reports Successful AGM Outcomes Fusion Antibodies Reports Strong Mid-Year Financials Fusion Antibodies Plc Announces Annual Report & AGM